These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15072826)

  • 1. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY; Olivo M; Tan BK; Bay BH
    Cancer Lett; 2004 Apr; 207(2):175-81. PubMed ID: 15072826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY; Bay BH; Olivo M
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY; Olivo M; Tan BK; Bay BH
    Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
    Du HY; Li Y; Olivo M; Yip GW; Bay BH
    Oncol Rep; 2006 Dec; 16(6):1397-402. PubMed ID: 17089067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Matrix metalloproteinase-1 in nasopharyngeal cancer cells by photoactivation of hypericin.
    Du H; Olivo M; Mahendran R; Bay BH
    Int J Oncol; 2004 Mar; 24(3):657-62. PubMed ID: 14767550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo.
    Du HY; Olivo M; Chen YJ; Yip G; Tan PH; Matsumoto K; Tsujimoto M; Bay BH
    Int J Mol Med; 2005 Nov; 16(5):865-8. PubMed ID: 16211256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
    Du H; Bay BH; Mahendran R; Olivo M
    Cancer Lett; 2006 Apr; 235(2):202-8. PubMed ID: 15935550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous expression of interleukin-8 and interleukin-10 in nasopharyngeal carcinoma cells and the effect of photodynamic therapy.
    Du H; Bay BH; Mahendran R; Olivo M
    Int J Mol Med; 2002 Jul; 10(1):73-6. PubMed ID: 12060853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
    Wang X; Guo Y; Yang S; Wang C; Fu X; Wang J; Mao Y; Zhang J; Li Y
    J Pharmacol Exp Ther; 2010 Sep; 334(3):847-53. PubMed ID: 20551295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
    Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
    Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
    Ali SM; Olivo M
    Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
    Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells.
    Du HY; Olivo M; Mahendran R; Huang Q; Shen HM; Ong CN; Bay BH
    Cell Mol Life Sci; 2007 Apr; 64(7-8):979-88. PubMed ID: 17385073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
    Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
    Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multifaceted photocytotoxic profile of hypericin.
    Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
    Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B; Zupkó I; de Witte PA
    Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour activity of photosensitized hypericin on A431 cell xenografts.
    Vandenbogaerde AL; Geboes KR; Cuveele JF; Agostinis PM; Merlevede WJ; De Witte PA
    Anticancer Res; 1996; 16(4A):1619-25. PubMed ID: 8712679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.